Integra Connect solutions can accelerate adoption of value-based, precision medicine efforts across the care continuum:

Precision Medicine
Solutions for Providers
Deliver high quality patient care and experiences, while managing costs.

Integra Connect
Platform
Advance research, improve drug development and maximize revenue.

Revenue Cycle Management
Solutions
Boost collections, accelerate the billing process, and find hidden growth potential.

Population Health
Solutions
Identify at-risk patients and populations for proactive intervention, optimize costs and quality performance, and excel under value-based payment models.

IntegraCloud
EHR
Understand the patient journey, improve work efficiency, integrate care and information flows, and easily analyze and report performance.

Precision Medicine Solutions
for Life Sciences
Identify opportunities for clinical research and drug development, support pipeline, and launch medicines for the benefit of patients
How Integra Connectis different
Integra Connect is driven to make specialty care practices clinically and financially successful through value-based, precision medicine. While other companies may focus on one of these areas, Integra Connect’s combined approach means providers, payers, and life sciences companies can harness value-based, precision medicine principles to improve their decision-making and make a difference in patients’ lives.
SCHEDULE A DEMOMake data-driven decisions with our Precision Medicine platform
Integra Connect’s precision medicine platform is the industry’s most comprehensive and advanced solution for providing personalized patient care.
LEARN MOREPrecision Medicine Solutions for Oncology Practices
Adopt a targeted, personalized and patient-centered approach to care with the aid of advanced analytics and expert guidance.
Precision Medicine Solutions for Life Sciences Companies
Identify opportunities for drug development, HEOR research, and improved patient outcomes with our industry-leading data services.
Our Leadership
Our leadership team is composed of experts with extensive real-world experience working in clinical settings.
Resources
Best practices for optimising performance under value-based reimbursement models, developed by our in-house experts.
Publications
Access content and gain insights about the role data plays in healthcare transformation and how data can empower informed decisions.
Videos
Watch videos and interviews about the future of healthcare in a value-based ecosystem including quality improvement and much more.
What the Industry is SayingAbout Integra Connect

New real-world data show potential of Trilaciclib to reduce the substantial burden of myelosuppression in patients with extensive-stage small-cell lung cancer treated with chemotherapy
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced results of a retrospective, observational study describing the substantial burden of myelosuppression and its impact on healthcare resource utilization (HCRU) in 3,277 patients being treated with chemotherapy for extensive-stage small-cell lung cancer (ES-SCLC). The study also described patient outcomes from 21 patients receiving trilaciclib prior to chemotherapy; of these, 17 received commercial trilaciclib in the real-world setting, and four received trilaciclib in clinical trials.
Read more
EVERSANA and Integra Connect Form Strategic Partnership to Advance Next Generation Oncology Commercialization Services
CHICAGO, EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, today announced a strategic partnership with Integra Connect, LLC, designed to support life sciences companies as they develop and commercialize new oncology treatments. EVERSANA and Integra Connect, the leading provider of value-based, precision medicine technologies and services for specialty care, will contribute market-leading expertise, real-world data and technologies to create a comprehensive longitudinal oncology patient database. Once available, life sciences companies will be able to leverage the database to optimize their decision-making across a product’s entire life cycle.
Read more
Integra Connect Welcomes New COO
WEST PALM BEACH, Fla. — Integra Connect, the leading provider of technologies and services for value-based specialty care and precision oncology, today announces the addition of Cory Wiegert as its new Chief Operating Officer (COO) to provide strategic leadership as the company expands with its integrated solutions for Precision Oncology, Population Health, Cloud EHR and Revenue Cycle management.
Read more